These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1362693)

  • 1. [Histologic evaluation of potential new beta-adrenolytics].
    Cizmáriková R; Pazin E; Hricková
    Cesk Farm; 1992 Oct; 41(7-8):264-5. PubMed ID: 1362693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of potential beta-adrenolytics on markers of enzyme activity in subcellular fractions of the cardiac muscle].
    Cizmáriková R; Gvozdjaková A; Kucharská J
    Ceska Slov Farm; 2000 May; 49(3):150-2. PubMed ID: 10953462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of 2-(2-hydroxy-3-isopropylaminopropoxy)-5-(propoxymethyl) acetophenone--a potential adrenoreceptor beta blocker affecting the function of myocardial mitochondria after administration of isoprenaline].
    Cizmáriková R; Gvozdjaková A; Kucharská J
    Ceska Slov Farm; 1997 Oct; 46(5):230-4. PubMed ID: 9600145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in basic nitrogen in a group of potential new beta- adrenolytics--derivatives of p-hydroxyacetophenone and p-hydroxypropiofenone].
    Cizmáriková R; Racanská E; Greksáková O
    Cesk Farm; 1993 Apr; 42(2):82-5. PubMed ID: 8104716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of lipolytic activity by 4-(3-isopropylamino-2-hydroxypropoxy)-3-(alkoxymethyl)acetophenone].
    Edelsteinová S; Cizmáriková R
    Pharmazie; 1991 Apr; 46(4):298-9. PubMed ID: 1679555
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of some potential beta-adrenolytics derivated from o-hydroxyacetophenone.
    Cizmáriková R; Racanská E; Dingová A; Greksáková O
    Pharmazie; 1994 May; 49(5):366-7. PubMed ID: 7912440
    [No Abstract]   [Full Text] [Related]  

  • 9. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
    Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
    Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic evaluation of p-hydroxyacetophenone derivatives as potential beta-adrenolytics].
    Racanská E; Kozlovský J
    Ceska Slov Farm; 1994 Jul; 43(4):169-70. PubMed ID: 7915177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

  • 12. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
    Iuzhakov SD; Sokolov SD; Vinogradova SM
    Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ultrastructural changes in the myocardium of rats during withdrawal syndrome after gradual decreasing of metipranolol doses.
    Lazarová Z
    Cor Vasa; 1992; 34(3):283-92. PubMed ID: 1363978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Derivatives of para-hydroxyacetophenone and para-hydroxypropiophenone as a potential new beta-adrenolytic agent].
    Cizmáriková R; Dingová A; Kozlovský J; Greksáková O
    Cesk Farm; 1990 Nov; 39(9):403-8. PubMed ID: 1982858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The potential co-cataractogenic effects of beta blockers in cataract models in the rat].
    Wegener A; Eckerskorn U; Hockwin O; Bours J
    Fortschr Ophthalmol; 1988; 85(6):695-8. PubMed ID: 2906029
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver tumors induced by a new beta-adrenoreceptor blocking agent in female rats.
    Ragnotti G; Presta M; Riboni L; Zavanella T
    J Natl Cancer Inst; 1982 Apr; 68(4):669-72. PubMed ID: 6121925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of pharmacological properties of various potential beta adrenolytics of the aryloxypropanolamine type].
    Béderová E; Edelsteinová S; Racanský V; Svec P
    Cesk Farm; 1982 Sep; 31(7):279-85. PubMed ID: 6128077
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601].
    Marchetti G; Merlo L; Noseda V
    Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of propranolol and flusoxolol on the lysosomal enzyme activity of the rat ventricular myocardium].
    Sysoliatina NA
    Eksp Klin Farmakol; 1992; 55(5):33-6. PubMed ID: 1363945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.